Vanguard Small-Cap ETF
VB - ETF AI Analysis
Top Page
Vanguard Small-Cap ETF (VB)
VB, the Vanguard Small-Cap ETF, has a solid overall rating, helped by strong holdings like Williams-Sonoma, Okta, EMCOR Group, and Natera, which show healthy financial performance, positive earnings sentiment, and growth initiatives such as AI and strategic expansions. However, weaker names like Moderna and Revolution Medicines, which face declining revenues, ongoing losses, and bearish technical trends, weigh on the fund’s rating. A key risk factor is exposure to several high-valuation and volatile growth and biotech stocks, which can make returns more sensitive to market swings.
VB vs. SPDR S&P 500 ETF (SPY)
- AUM
- 76.92B
- Region
- North America
- Expense Ratio
- 0.03%
- Beta
- 0.92
- Issuer
- Vanguard
- Inception Date
- Jan 26, 2004
- Dividend Yield
- 1.29%
- Asset Class
- Equity
- Index Tracked
- Morningstar US Small Cap TR USD
VB Summary
Vanguard Small-Cap ETF (VB) is a fund that follows the Morningstar US Small Cap Index, focusing on smaller U.S. companies with room to grow. It spreads your money across many industries, including technology, health care, and industrials. Some well-known names in the fund are Moderna and Twilio, along with many other smaller firms you may not recognize yet. Investors might choose VB to add growth potential and diversification beyond large, familiar companies. A key risk is that small-cap stocks can be more volatile, so the value of this ETF can move up and down sharply with the market.
How much will it cost me?
This ETF has an expense ratio of 0.03%, which means you’ll pay about $0.30 per year for every $1,000 invested. That’s much lower than the average because it’s a passively managed index fund that simply tracks a small-cap stock index instead of paying managers to pick individual stocks.
What would affect this ETF?
VB focuses on U.S. small-cap stocks, so it could benefit if the U.S. economy grows steadily, innovation in technology and health care accelerates, and investor appetite for riskier growth companies increases, helping its top holdings like Natera, Twilio, and Moderna. On the other hand, higher interest rates, an economic slowdown that hits smaller businesses harder, or tighter regulations on tech and biotech firms could weigh on the fund’s performance and make its returns more volatile.
VB Top 10 Holdings
VB’s story is all about fast-moving U.S. small caps, with a clear tilt toward innovative tech and health care names. Okta, Natera, Illumina, and even volatile Moderna have been rising, giving the fund a strong growth engine. Pure Storage adds more tech firepower, while Twilio’s mixed recent performance and laggards like Credo Technology and EMCOR occasionally hit the brakes. Overall, the ETF is broadly diversified, but its top holdings show a clear bet on smaller, high-growth U.S. innovators to drive long-term returns.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Natera | 0.70% | $1.27B | $41.98B | 35.50% | 73Outperform | |
| Everpure | 0.50% | $898.97M | $33.57B | 22.60% | 64Neutral | |
| Moderna | 0.49% | $893.05M | $79.63B | 689.69% | 59Neutral | |
| Revolution Medicines | 0.48% | $873.35M | $34.57B | 126.44% | 52Neutral | |
| Illumina | 0.44% | $798.91M | $30.63B | 72.18% | 71Outperform | |
| Okta | 0.43% | $780.32M | $30.51B | 141.40% | 75Outperform | |
| Twilio | 0.39% | $705.93M | $30.04B | 62.35% | 70Neutral | |
| EMCOR Group | 0.37% | $672.00M | $28.29B | 5.15% | 73Outperform | |
| Williams-Sonoma | 0.37% | $667.33M | $30.63B | 43.89% | 75Outperform | |
| Atmos Energy | 0.36% | $653.21M | $29.22B | -2.03% | 66Neutral |
VB Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VB, the sentiment is Negative. The current price of 283.65 is below the 20-day moving average (MA) of 289.97, below the 50-day MA of 289.02, and below the 200-day MA of 286.06, indicating a bearish trend. The MACD of -0.79 indicates Positive momentum. The RSI at 42.36 is Neutral, neither overbought nor oversold. The STOCH value of 16.98 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for VB.
VB Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $283.65 | $305.00(7.53% Upside) | $76.92B | 0.03% | 66Neutral | |
| $137.90 | $168.21(21.98% Upside) | $102.98B | 0.06% | 65Neutral | |
| $270.12 | $366.50(35.68% Upside) | $74.62B | 0.19% | 63Neutral | |
| $32.10 | $42.47(32.31% Upside) | $21.39B | 0.03% | 63Neutral | |
| $109.11 | $150.94(38.33% Upside) | $16.02B | 0.06% | 61Neutral | |
| $53.61 | $65.65(22.47% Upside) | $15.55B | 0.03% | 66Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VB | Vanguard Small-Cap ETF | 283.65 | 39.64 | 16.24% | |
| IJR | iShares Core S&P Small Cap ETF | 137.90 | 23.80 | 20.85% | |
| IWM | iShares Russell 2000 ETF | 270.12 | 36.89 | 15.82% | |
| SCHA | Schwab U.S. Small-Cap ETF | 32.10 | 5.16 | 19.14% | |
| VTWO | Vanguard Russell 2000 ETF | 109.11 | 15.05 | 16.00% | |
| SPSM | SPDR Portfolio S&P 600 Small Cap ETF | 53.61 | 9.28 | 20.94% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
